A Comparative Study on the Hemato-Biochemical and Immunological Effects of the Hexavalent FMD Vaccine Alone or in Combination with Trivalent FMD Vaccine in Cattle


Foot and mouth disease is the most contagious disease of mammals and has a great potential for causing severe economic loss in susceptible cloven-hoofed animals. Routine prophylactic vaccination in Egypt from 2012 till now has been conducted with Trivalent and/or hexavalent vaccine of MERIAL, against virus strains (O manisa + O-3039 + A Iran 05 + A Saudi 95 + Asia 1 + Sat2). This study aimed to evaluate the hemato-biochemical and immunological changes associated with the use of hexavalent vaccine alone or in combination with trivalent FMD vaccine. This study was carried out on 24 cattle divided into three groups eight cattle each. Group I served as control. Group II were selected from farms vaccinated with hexavalent FMD vaccine. Group III were selected from farms vaccinated with a combination of trivalent and hexavalent FMD vaccine. The results showed that both vaccinated groups showed a significant increase in total leukocytic count. Sera from hexavalent-trivalent vaccinated cattle demonstrated a significant increase in serum cortisol concentrations. Significant increase in serum activity of aspartate aminotransferase was recorded in animals vaccinated with a combination of hexavalent and trivalent vaccine. In addition, both regimes resulted in a significant increase in serum blood urea nitrogen compared to control. Both regimes induced a significant increase in serum levels of ceruloplasmin while phagocytic activity of neutrophils and phagocytic index was enhanced only by the hexavalent vaccine. Both vaccinated groups had significantly increased serum values of gamma globulins. These results suggested that hexavalent vaccine produced higher levels of safety and protective effects against FMD in cattle as compared to those produced by a combination of hexavalent and trivalent vaccines. It is also advisable to include the hexavalent vaccine within the program of obligatory and imperative vaccination against FMD.

Share and Cite:

Shawky, S. , Thabet, N. , Orabi, S. and Nayel, M. (2016) A Comparative Study on the Hemato-Biochemical and Immunological Effects of the Hexavalent FMD Vaccine Alone or in Combination with Trivalent FMD Vaccine in Cattle. Journal of Biosciences and Medicines, 4, 16-26. doi: 10.4236/jbm.2016.41003.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Radostits, O.M., Gay, C.C., Blood, D.C. and Hinchkiff, K.W. (2000) A Text Book of Veterinary Medicine. 9th Edition, ELBS and Baillier Tindall, London, 563-618.
[2] Park, J. (2013) Requirements for Improved Vaccines against Foot-and-Mouth Disease Epidemics. Clinical and Experimental Vaccine Research, 2, 8-18.
[3] Doel, T.R. (2003) FMD Vaccines. Virus Research, 91, 81-99.
[4] Aidaros, H.A. (2002) Regional Status and Approaches to Control and Eradication of FMD in the Middle East and North Africa. Rev. sci. tech. Off. int. Epiz., 21, 451-458.
[5] Knowles, N.J. and Samuel, A.R. (2003) Molecular Epidemiology of Foot-and-Mouth Disease Virus. Virus Research, 91, 65-80.
[6] Abd El-Rahman, A.O., Farag, M.A., El-Kilany, S., Eman, M.A, Abo Yazed, M. and Zeidan, S. (2006) Isolation and Identification of FMDV During an Outbreak of 2006 in Egypt. Kafr EL-Sheikh Vet. Med. J., 4, 451-464.
[7] Zaher, K.S. and Ahmed, W.M. (2014) The Role of Foot and Mouth Disease Outbreak in 2012 on Egyptian Small Ruminants and Pigs. Global Veterinaria, 12, 583-587.
[8] Ghoneim, N.H., Abdel-Karim, A.K.M., El-Shehawy, L. and AbdelMoein, K.A. (2010) FMD in Animals in Sharkia Governorate, Egypt. Transboundary and Emerging Diseases, 57, 19-21.
[9] Ahmed, H.A., Salem, S.A., Habashi, A.R., Arafa, A.A., Aggour, M.G., Salem, G.H., Gaber, A.S., Selem, O., Abdelkader, S.H., Knowles, N.J., Madi, M., Valdazo-González, B., Wadsworth, J., Hutchings, G.H., Mioulet, V., Hammond, J.M. and King, D.P. (2012) Emergence of Foot-and-Mouth Disease Virus SAT 2 in Egypt during 2012. Transboundary and Emerging Diseases, 59, 476-481.
[10] Valdazo-González, B., Knowles, N.J., Hammond, J.M. and King, D.P. (2012) Genome Sequences of SAT 2 Foot- and-Mouth Disease Viruses from Egypt and Palestinian Autonomous Territories (Gaza Strip). Journal of Virology, 86, 8901-8902.
[11] Hall, M.D., Knowles, N.J., Wadsworth, J., Rambaut, A. and Woolhouse, M.E.J. (2013) Reconstructing Geographical Movements and Host Species Transitions of Foot-and-Mouth Disease Virus Serotype SAT 2. mBio, 4, e00591-13.
[12] Kahn, S., Geale, D.W., Kitching, P.R., Bouffard, A., Allard, D.G. and Duncan, J.R. (2002) Vaccination against Foot-and-Mouth Disease: The Implications for Canada. Canadian Veterinary Journal, 43, 349-354.
[13] Sutmoller, P. and Casas Olascoaga, R. (2003) The Risks Posed by the Importation of Animals Vaccinated against Foot and Mouth Disease and Products Derived from Vaccinated Animals: A Review. Revue Scientifique et Technique (International Office of Epizootics), 22, 823-835.
[14] Lu, Z. (2007) Development and Validation of a 3ABC Indirect ELISA for Differentiation of Foot-and-Mouth Disease Virus Infected from Vaccinated Animals. Veterinary Microbiology, 125, 157-169.
[15] Feldman, B.F., Zinkl, J.G. and Jain, N.C. (2000) Schalms Veterinary Haematology. 5th Edition, Williams and Wilkins, Philadelphia, 21-100.
[16] Sáiza, M., Núnez, J.I., Jimenez-Clavero, M.A., Baranowski, E. and Sobrino, F. (2002) Foot-and-Mouth Disease Virus: Biology and Prospects for Disease Control. Microbes and Infection, 4, 1183-1192.
[17] Ortega, E., Rodriges, M.J., Barriga, C. and Forner, M.A. (1996) Corticosterone, Prolactin and Thyroid Hormones as Hormonal Mediators of Stimulated Phagocytic Capacity of Peritoneal Macrophages after High-Intensity Exercise. International Journal of Sports Medicine, 17, 149-155.
[18] Snedecor, G.W. and Cochran, W.G. (1980) Statistical Methods. 7th Edition, Iowa State University Press, Ames.
[19] Orsel, K. and Bouma, A. (2009) The Effect of Foot-and-Mouth Disease (FMD) Vaccination on Virus Transmission and the Significance for the Field. Canadian Veterinary Journal, 50, 1059-1063.
[20] Knight-Jones, T.J.D. and Rushton, J. (2013) The Economic Impacts of Foot and Mouth Disease—What Are They, How Big Are They and Where Do They Occur? Preventive Veterinary Medicine, 112, 161-173.
[21] FAO (2012) Foot-and-Mouth Disease Caused by Serotype SAT2 in Egypt and Libya: A Regional Concern for Animal Health in North Africa and the Middle East. EMPRES Watch, 25.
[22] El-Shehawy, L.I., Abu-Elnaga, H.I., Rizk, S.A., El-Kreem, A.S.A., Mohamed, A.A. and Fawzy, H.G. (2014) Molecular Differentiation and Phylogenetic Analysis of the Egyptian Foot-and-Mouth Disease Virus SAT2. Archives of Virology, 159, 437-443.
[23] Elhaig, M.M. and Elsheer, M.N. (2014) Molecular Investigation of Foot-and-Mouth Disease Virus in Domestic Bovids from Gharbia, Egypt. Tropical Animal Health and Production, 46, 1455-1462.
[24] Kandeil, A., El-Shesheny, R., Kayali, G., Moatasim, Y., Bagato, O., Darwish, M., Gaffar, A., Younes, A., Farag, T., Kutkat, M.A. and Ali, M.A. (2013) Characterization of the Recent Outbreak of Foot-and-Mouth Disease Virus Serotype SAT2 in Egypt. Archives of Virology, 158, 619-627.
[25] Kim, M., Yang, J., Upadhaya, S.D., Lee, H., Yun, C. and Ha, J.K. (2011) The Stress of Weaning Influences Serum Levels of Acute-Phase Proteins, Iron-Binding Proteins, Inflammatory Cytokines, Cortisol, and Leukocyte Subsets in Holstein Calves. Journal of Veterinary Science, 12, 151-157.
[26] Dhabhar, F.S. (2009) Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. Neuroimmunomodulation, 16, 300-317.
[27] Martin, L.B. (2009) Stress and Immunity in Wild Vertebrates: Timing Is Everything. General and Comparative Endocrinology, 163, 70-76.
[28] Max’s House (2015) Max’s House Feline Health & Behavior Monthly Newsletter Vaccination Protocols in Cats.
[29] Kumar, V. and Sharma, A. (2010) Neutrophils: Cinderella of Innate Immune System. International Immunopharmacology, 10, 1325-1334.
[30] Brown, F. (1999) Foot-and-Mouth Disease and Beyond: Vaccine Design, Past, Present and Future. In: Calisher, C.H. and Horzinek, M.C., Eds., 100 Years of Virology, Archives of Virology. Supplementa, Vol. 15, Springer, Vienna, 179-188.
[31] Duncan, J.R., Prasse, K.W. and Mahaffey, E.A. (1994) Veterinary Laboratory Medicine: Clinical Pathology. 3rd Edition, Iowa State University Press, Ames.
[32] Kaneko, J.J., Harvey, J.W. and Bruss, M.L. (1997) Clinical Biochemistry of Domestic Animals. 5th Edition, Academic Press, San Diego.
[33] Ognean, L., Chiurciu, C., Zavoiu, F., Cernea, C., Cernea, M., Todoran, C., Moldovan, M. and Trinca, S. (2010) The Relevance of Some Physiological Parameters in Evaluating the Safety of Two Vaccine Formulation against Contagious Agalaxia in Goats. Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. Agriculture, 67, 166-178.
[34] Kohn, R.A., Dinneen, M.M. and Russek-Cohen, E. (2005) Using Blood Urea Nitrogen to Predict Nitrogen Excretion and Efficiency of Nitrogen Utilization in Cattle, Sheep, Goats, Horses, Pigs, and Rats. Journal of Animal Science, 83, 879-889.
[35] Rigdena, R.C., Carrascoa, C.P., Barnettb, P.V., Summerfielda, A. and McCullough, K.C. (2003) Innate Immune Responses Following Emergency Vaccination against Foot-and-Mouth Disease Virus in Pigs. Vaccine, 21, 1466-1477.
[36] Chhabra, R., Sharma, R. and Kakker, N.K. (2004) Comparative Immunogenecity of Foot and Mouth Disease Virus Antigens in FMD-Haemorrhagic Septicaemia Combined Vaccine and FMD Vaccine Alone in Buffalo Calves. Indian Journal of Experimental Biology, 42, 259-264.
[37] Vibha, J., Degroot, A., Cousens, L., Awwad, M., Kropshofer, H. and Wakshull, E. (2013) T-Cell Dependent Immunogenicity of Protein Therapeutics: Preclinical Assessment and Mitigation. Clinical Immunology, 149, 534-555.
[38] Ceron, J.J., Eckersall, P.D. and Martinez-Subiela, S. (2005) Acute Phase Proteins in Dogs and Cats: Current Knowledge and Future Perspectives. Veterinary Clinical Pathology, 34, 85-99.
[39] Gursel, F.E., Durak, M.H. and Altiner, A. (2010) Serum Ceruloplasmin Levels in Ewes Fed Deficient-Energy during Late Pregnancy. Journal of Animal and Veterinary Advances, 9, 820-825.
[40] Arthington, J.D., Cooke, R.F., Maddock, T.D., Araujo, D.B., Moriel, P., Dilorenzo, N. and Lamb, G.C. (2013) Effects of Vaccination on the Acute-Phase Protein Response and Measures of Performance in Growing Beef Calves. Journal of Animal Science, 91, 1831-1837.
[41] Weber, C.E. (1984) Copper Response to Rheumatoid Arthritis. Medical Hypotheses, 15, 333-348.
[42] Lomborg, S.R., Nielsen, L.R., Heegaard, P.M.H. and Jacobsen, S. (2008) Acute Phase Proteins in Cattle after Exposure to Complex Stress. Veterinary Research Communications, 32, 575-582.
[43] Yun, C., Wynn, P. and Ha, J.K. (2014) Stress, Acute Phase Proteins and Immune Modulation in Calves. Animal Production Science, 54, 1561-1568.
[44] Doel, T.R. (1996) Natural and Vaccine-Induced Immunity to Foot and Mouth Disease: The Prospects for Improved Vaccines. Revue Scientifique et Technique, 15, 883-911.
[45] Schley, D., Tanaka, R.J., Leungchavaphongse, K., Shahrezaei, V., Ward, J. and Grant, C. (2012) Modelling the Influence of Foot-and-Mouth Disease Vaccine Antigen Stability and Dose on the Bovine Immune Response. PLoS ONE, 7, e30435.
[46] Marketon, J.I. and Glaser, R. (2008) Stress Hormones and Immune Function. Cellular Immunology, 252, 16-26.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.